News

| CRISPR Medicine | This is an overview of our news stories

New Partnership Announcement: CMN x EDUGENE

Aug. 5, 2025

We’re excited to announce a strategic partnership between CRISPR Medicine News (CMN) and EDUGENE - coming together to advance CRISPR and biotechnology...

CRISPR-Edited Beta Cells Avoid Immune Rejection...

CMN Briefs

Aug. 5, 2025

CRISPR-Cas12b technology was used to edit allogeneic donor islet cells for transplantation into a man with long-standing type 1 diabetes....

CMN Weekly (1 August 2025) - Your Weekly CRISPR...

CMN Weekly

Aug. 1, 2025

Some of the best links we picked up around the internet

YOLT-203 Awarded EMA Orphan Drug Designation for...

Jul. 30, 2025

YolTech Therapeutics announced earlier this week that the European Medicines Agency has granted Orphan Drug Designation to YOLT-203, its...

CMN Weekly (25 July 2025) - Your Weekly CRISPR...

CMN Weekly

Jul. 25, 2025

Some of the best links we picked up around the internet

Extended: CRISPR does not drive resistance in HIV...

CMN Special

Jul. 22, 2025

Building on prior work demonstrating HIV-1 elimination using dual CRISPR-Cas9 editing and antiretroviral therapy in humanised mice, this study by...

CMN Weekly (18 July 2025) - Your Weekly CRISPR...

CMN Weekly

Jul. 18, 2025

Some of the best links we picked up around the internet

Clinical Update: YolTech's Base-Editing Therapy...

CMN Clinical

Jul. 16, 2025

YolTech Therapeutics announced on Monday that the Chinese National Medical Products Administration has approved its IND application for YOLT-101 in...